Eczema drug nemolizumab put to the vaccine test
NCT ID NCT04365387
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether nemolizumab, a drug for moderate-to-severe eczema, interferes with the body's ability to respond to tetanus and meningococcal vaccines. 242 adults and teens with eczema received either nemolizumab or a placebo, plus the vaccines. The goal was to see if the drug dampens the immune response, which could affect how well vaccines protect them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nemolizumab
What this could lead to
If successful, this could show that nemolizumab does not weaken vaccine responses, allowing people with eczema to get vaccinated while on treatment.
What could go wrong
This is a small, early-phase study (Phase 2) focused on immune response to vaccines, not on treating eczema itself. Results may not apply to all patients or other vaccines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Galderma Investigational Site (SIte#8870)
Boca Raton, Florida, 33433, United States
-
Galderma Investigational Site (Site#8003)
Webster, Texas, 77598, United States
-
Galderma Investigational Site (Site#8033)
Clinton Township, Michigan, 48038-1137, United States
-
Galderma Investigational Site (Site#8129)
Fort Gratiot, Michigan, 48059, United States
-
Galderma Investigational Site (Site#8130)
Los Angeles, California, 90045, United States
-
Galderma Investigational Site (Site#8142)
Indianapolis, Indiana, 46250, United States
-
Galderma Investigational Site (Site#8200)
Goodlettsville, Tennessee, 37072, United States
-
Galderma Investigational Site (Site#8213)
Ormond Beach, Florida, 32174, United States
-
Galderma Investigational Site (Site#8245)
Dallas, Texas, 75231, United States
-
Galderma Investigational Site (Site#8329)
San Antonio, Texas, 78229-3409, United States
-
Galderma Investigational Site (Site#8353)
Yardley, Pennsylvania, 19067, United States
-
Galderma Investigational Site (Site#8391)
Hialeah, Florida, 33013, United States
-
Galderma Investigational Site (Site#8420)
Portsmouth, New Hampshire, 03801, United States
-
Galderma Investigational Site (Site#8428)
Philadelphia, Pennsylvania, 19104, United States
-
Galderma Investigational Site (Site#8447)
Fort Smith, Arkansas, 72916, United States
-
Galderma Investigational Site (Site#8532)
Overland Park, Kansas, 66215, United States
-
Galderma Investigational Site (Site#8578)
Cerritos, California, 90703, United States
-
Galderma Investigational Site (Site#8739)
Normal, Illinois, 61761, United States
-
Galderma Investigational Site (Site#8764)
Tampa, Florida, 33613, United States
-
Galderma Investigational Site (Site#8777)
Charleston, South Carolina, 29407, United States
-
Galderma Investigational Site (Site#8786)
Clearwater, Florida, 33765, United States
-
Galderma Investigational Site (Site#8787)
Plano, Texas, 75093, United States
-
Galderma Investigational Site (Site#8788)
Orlando, Florida, 32801, United States
-
Galderma Investigational Site (Site#8791)
Fresno, California, 93720, United States
-
Galderma Investigational Site (Site#8792)
Doral, Florida, 33122, United States
-
Galderma Investigational Site (Site#8793)
Towson, Maryland, 21204, United States
-
Galderma Investigational Site (Site#8795)
Shelby, North Carolina, 28150, United States
-
Galderma Investigational Site (Site#8812)
Metairie, Louisiana, 70005, United States
-
Galderma Investigational Site (Site#8813)
Los Angeles, California, 90057, United States
-
Galderma Investigational Site (Site#8817)
Katy, Texas, 77494, United States
-
Galderma Investigational Site (Site#8828)
Kew Gardens, New York, 11415, United States
-
Galderma Investigational Site (Site#8831)
Anaheim, California, 92801, United States
-
Galderma Investigational Site (Site#8833)
Inglewood, California, 90301, United States
-
Galderma Investigational Site (Site#8836)
Jacksonville, Florida, 32256, United States
-
Galderma Investigational Site (Site#8837)
Pomona, California, 91767, United States
-
Galderma Investigational Site (Site#8839)
Tampa, Florida, 33615, United States
-
Galderma Investigational Site (Site#8840)
Ocoee, Florida, 34761, United States
-
Galderma Investigational Site (Site#8841)
Medford, Oregon, 97504, United States
-
Galderma Investigational Site (Site#8843)
Sweetwater, Florida, 33172, United States
-
Galderma Investigational Site (Site#8844)
Orem, Utah, 84058, United States
-
Galderma Investigational Site (Site#8845)
Huntington Beach, California, 92647, United States
-
Galderma Investigational Site (Site#8846)
Austin, Texas, 78742, United States
-
Galderma Investigational Site (Site#8847)
Las Vegas, Nevada, 89118, United States
-
Galderma Investigational Site (Site#8848)
Las Vegas, Nevada, 89144, United States
-
Galderma Investigational Site (Site#8849)
Troy, Michigan, 48084, United States
-
Galderma Investigational Site (Site#8850)
Margate, Florida, 33063, United States
-
Galderma Investigational Site (Site#8851)
Miami, Florida, 33135, United States
-
Galderma Investigational Site (Site#8854)
Canoga Park, California, 91303, United States
-
Galderma Investigational Site (Site#8855)
Beaumont, Texas, 77702, United States
-
Galderma Investigational Site (Site#8856)
Ormond Beach, Florida, 32174, United States
-
Galderma Investigational Site (Site#8856)
Ormond Beach, Florida, 33174, United States
-
Galderma Investigational Site (Site#8857)
Oklahoma City, Oklahoma, 73118, United States
-
Galderma Investigational Site (Site#8858)
Long Beach, California, 90806, United States
-
Galderma Investigational Site (Site#8868)
Houston, Texas, 77004, United States
-
Galderma Investigational Site (Site#8873)
Scottsdale, Arizona, 85260, United States
-
Galderma Investigational Site (Site#8876)
Bridgeton, Missouri, 63044, United States
-
Galderma Investigational Site (Site#9919)
Raleigh, North Carolina, 27617, United States
-
Galderma Investigational Site (Site#9921)
Miami Lakes, Florida, 33014, United States
-
Galderma Investigational Site (Site#9922)
Phoenix, Arizona, 85018, United States
-
Galderma Investigational Site (Site#9924)
Raritan, New Jersey, 08869, United States
-
Galderma Investigational Site (Site#9935)
Springville, Utah, 84663, United States
-
Galderma Investigational Site 2 (Site#8816)
Tampa, Florida, 33613, United States
-
Galderma Investigational Site 2 (Site#8833)
Inglewood, California, 90301, United States
-
Galderma Investigational Site 2 (Site#8864)
Las Vegas, Nevada, 89144, United States